![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Population-PK Analysis to Guide Dosing Window Following Lenacapavir SC Administration
|
|
|
CROI 2023 Feb 20-23
Naveed A. Shaik,1* Francesco Bellanti,2 Craig Comisar,2 Martin Rhee,1 Sandhya Girish,1 Ramesh Palaparthy,1 Renu Singh1
1Gilead Sciences, Inc., Foster City, CA; 2Certara, Inc., Princeton, NJ
![0221231](../images/022123/022123-8/0221231.gif)
![0221232](../images/022123/022123-8/0221232.gif)
![0221233](../images/022123/022123-8/0221233.gif)
![0221234](../images/022123/022123-8/0221234.gif)
![0221235](../images/022123/022123-8/0221235.gif)
![0221236](../images/022123/022123-8/0221236.gif)
![0221237](../images/022123/022123-8/0221237.gif)
![0221238](../images/022123/022123-8/0221238.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|